Endoscopic ultrasound-guided fine-needle aspiration cytology diagnosis of intraductal papillary mucinous neoplasm of the pancreas is highly predictive of pancreatic neoplasia

Diagnostic Cytopathology

Volumn 34, Issue 7, 2006, Pages 457-462

  Emerson, Robert E ^a,b   Randolph, Melissa L ^a   Cramer, Harvey M ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

EUS; FNA; Intraductal papillary mucinous neoplasm; Pancreas

Indexed keywords

MUCIN;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CHRONIC PANCREATITIS; CONTROLLED STUDY; CYTOPATHOLOGY; ENDOSCOPIC ECHOGRAPHY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PANCREAS PSEUDOCYST; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADENOCARCINOMA, MUCINOUS; BIOPSY, FINE-NEEDLE; CARCINOMA, PANCREATIC DUCTAL; CARCINOMA, PAPILLARY; ENDOSONOGRAPHY; HUMANS; PANCREATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 33745726565     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.20446     Document Type: Article

References (43)

1. Prasad S, Sahani D, Nasser S, et al. Intraductal papillary mucinous tumors of the pancreas. Abdom Imaging 2003;28:357-365.
2. Recine M, Kaw M, Evans D, Krishnamurthy S. Fine-needle aspiration cytology of mucinous tumors of the pancreas. Cancer 2004;102:92-99.
3. Song M, Lee S, Kim M, et al. EUS in the evaluation of pancreatic cystic lesions. Gastroinlest Endosc 2003;57:891-896.
4. Taouli B, Vilgrain V, O'Toole D, Vullierme M, Terris B, Menu Y. Intraductal papillary mucinous tumors of the pancreas: Features with multimodality imaging. J Comput Assist Tomogr 2002;26:223-231.
5. Yamaguchi K, Tanaka M. Intraductal papillary-mucinous tumor of the pancreas: A historical review of the nomenclature and recent controversy. Pancreas 2001;23:12-19.
6. Loftus E, Olivares-Pakzad B, Balls K, et al. Intraductal papillary-mucinous tumors of the pancreas: Clinicopathologic features, outcome, and nomenclature. Gastroenterology 1996;110:1909-1918.
7. Adsay N. The "new kid on the block:" Intraductal papillary mucinous neoplasms of the pancreas: Current concepts and controversies. Surgery 2003;133:459-463.
8. Suzuki Y, Atomi Y, Sugiyama M, et al. Cystic neoplasm of the pancreas: A Japanese multiinstitutional study of intraductal papillary mucinous tumor and mucinous cystic tumor. Pancreas 2004;28:241-246.
9. Lai R, Stanley M, Bardales R, Linzie B, Mallery S. Endoscopic ultrasound-guided pancreatic duct aspiration: Diagnostic yield and safety. Endoscopy 2002;34:715-720.
10. Adsay N, Merati K, Basturk O, et al. Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: Deliniation of an "intestinal" pathway of carcinogenesis in the pancreas. Am J Surg Pathol 2004;28:839-848.
11. Kobari M, Egawa S, Shibuya K, et al. Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: Differences in clinical characteristics and surgical management. Arch Surg 1999;134:1131-1136.
12. Siech M, Tripp K, Schmidt-Rohlfing B, Mattfeldt T, Oorich J, Beger H. Intraductal papillary mucinous tumor of the pancreas. Am J Surg 1999;177:117-120.
13. Sugiyama M, Atomi Y. Intraductal papillary mucinous tumors of the pancreas: Imaging studies and treatment strategies. Ann Surg 1999;228:685-691.
14. Traverse L. Surgical treatment of intraductal papillary mucinous neoplasms of the pancreas: The aggressive approach. J Gastrointest Surg 2002;6:662-663.
15. Seki M, Yanagisawa A, Ohta H, et al. Surgical treatment of intraductal papillary-mucinous tumor of the pancreas: Operative indications based on surgico-pathologic study focusing on invasive carcinoma derived from IPMT. J Hepatobiliary Pancreat Surg 2003;10:147-155.
16. Fernandez-Del Castillo C. Surgical treatment of intraductal papillary mucinous neoplasms of the pancreas: The conservative approach. J Gastrointest Surg 2002;6:660-661.
17. Kamisawa T, Fujiwara T, Tu Y, et al. Long-term follow-up of intraductal papillary adenoma of the pancreas. J Gastroenterol 2002;37:868-873.
18. Shimuzu Y, Yasui K, Morimoto T, Torii A, Yamao K, Ohhashi K. Case of intraductal papillary mucinous tumor (noninvasive adenocarcinoma) of the pancreas resected 27 years after onset. Int J Pancreatol 1999;26:93-98.
19. Barbe L, Levy P, Mal F, Gayet B. Benign intraductal papillary-mucinous tumors of the pancreas with a 30-year follow-up. Gastroenterol Clin Biol 1998;22:91-93.
20. Jung I, Shim C, Cheon Y, et al. Invasive intraductal papillary mucinous tumor of the pancreas with simultaneuos invasion of the stomach and duodenum. Endoscopy 2004;36:186-189.
21. Cellier C, Cuillerier E, Palazzo L, et al. Intraductal papillary and mucinous tumors of the pancreas: Accuracy of preoperative computed tomography, endoscopic retrograde pancreatography and endoscopic ultrasnography, and long-term outcome in a large surgical series. Gastrointest Endosc 1998;47:42-49.
22. Sohn T, Yeo C, Cameron J, Iacobuzio-Donahue C, Hruban R, Lillemoe K. Intraductal papillary mucinous neoplasms of the pancreas: An increasingly recognized clinicopathologic entity. Ann Surg 2001;234:313-322.
23. Nakagohri T, Konishi M, Inoue K, Tanizawa Y, Kinoshita T. Invasive adenocarcinoma derived from intraductal papillary mucinous carcinoma of the pancreas. Hepatogastroenterology 2004;51:1480-1483.
24. Kubosawa H, Uehara T, Watanabe Y, et al. Intraductal papillary mucinous tumors of the pancreas. Hepatogastroenterology 2004;51:1489-1494.
25. Paal E, Thompson L, Przygodzki R, Bratthauer G, Heffess C. A clinicopathologic and immunohistochemical study of 22 intraductal papillary mucinous neoplasms of the pancreas, with a review of the literature. Mod Pathol 1999;12:518-528.
26. Adsay N, Conlon K, Zee S, Brennan M, Klimstra D. Intraductal papillary-mucinous neoplasms of the pancreas: An analysis of in situ and invasive carcinomas in 28 patients. Cancer 2002;94:62-77.
27. Adsay N, Merati K, Andea A, et al. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: Differential expression of MUC1 and MUC2 supports the existence of two seperate pathways of carcinogenesis. Mod Pathol 2002;15:1087-1095.
28. Sedlack R, Affi A, Vazquez-Sequeiros E, Norton I, Clain J, Wiersma M. Utility of EUS in the evaluation of cystic pancreatic lesions. Gastrointest Endosc 2002;56:543-547.
29. Aithal G, Chen R, Cunningham J, et al. Accuracy of EUS for detection of intraductal papillary mucinous tumor of the pancreas. Gastrointest Endosc 2002;56:701-707.
30. Ahmad N, Kochman M, Brensinger C, et al. Intraobserver agreement among endosonographers for the diagnosis of neoplastic versus nonneoplastic pancreatic cystic lesions. Gastrointest Endosc 2003;58:59-64.
31. Voss M, Hammel P, Molas G, et al. Value of endoscopic ultrasound guided fine needle aspiration biopsy in the diagnosis of solid pancreatic masses. Gut 2000;46:244-249.
32. Williams D, Sahai A, Aabakken L, et al. Endoscopic ultrasound guided fine needle aspiration biopsy: A large single centre experience. Gut 1999;44:720-726.
33. Kitagawa Y, Unger T, Taylor S, Kozarek R, Traverse L. Mucus is a predictor of better prognosis and survival in patients with intraductal papillary mucinous tumor of the pancreas. J Gastrointest Surg 2003;7:12-18.
34. Doi R, Fujimoto K, Wada M, Imamura M. Surgical management of intraductal papillary mucinous tumor of the pancreas. Surgery 2002;132:80-85.
35. Yamao K, Ohashi K, Nakamura T, et al. Evaluation of various imaging methods in the differential diagnosis of intraductal papillary-mucinous tumor (IPMT) of the pancreas. Hepatogastroenterology 2001;48:962-966.
36. Kubo H, Chijiiwa Y, Akahoshi K, et al. Intraductal papillary-mucinous tumors of the pancreas: Differential diagnosis between benign and malignant tumors by endoscopic ultrasonography. Am J Gastroenterol 2001;96:1429-1434.
37. Shabaik A. Endoscopic ultrasound-guided fine needle aspiration cytology of intraductal papillary mucinous tumor of the pancreas. A case report. Acta Cytol 2003;47:657-662.
38. Lee M, Lee H, Kim W, Choi Y, Yang M. Expression of mucins and cytokeratins in primary carcinomas of the digestive system. Mod Pathol 2003;16:403-410.
39. Dodd L, Farrell T, Layfield L. Mucinous cystic tumor of the pancreas: An analysis of FNA characteristics with an emphasis on the spectrum of malignancy associated features. Diagn Cytopathol 1995;2:113-119.
40. Inoue H, Tsuchida A, Kawasaki Y, Fujimoto Y, Yamasaki S, Kajiyama G. Preoperative diagnosis of intraductal papillary-mucinous tumors of the pancreas with attention to telomerase activity. Cancer 2001;91:35-41.
41. Niijima M, Yamaguchi T, Ishihara T, et al. Immunohistochemical analysis and in situ hybridization of cyclooxygenase-2 expression in intraductal papillary mucinous tumors of the pancreas. Cancer 2002;94:1565-1573.
42. Satoh K, Kaneko K, Hirota M, Toyota T, Shimosegawa T. The pattern of CPP32/caspase-3 expression reflects the biological behavior of the human pancreatic duct cell tumors. Pancreas 2000;21:352-357.
43. Kawahira H, Kobayashi S, Kaneko K, Asano T, Ochiai T. p53 protein expression in intraductal papillary mucinous tumors (IPMT) of the pancreas as an indicator of tumor malignancy. Hepatogastroenterology 2000;47:973-977.